Studies on the interaction between TWEAK and the death receptor WSL-1/TRAMP (DR3)

被引：47
作者：
Kaptein, A
Jansen, M
Dilaver, G
Kitson, J
Dash, L
Wang, E
Owen, MJ
Bodmer, JL
Tschopp, J
Farrow, SN
机构：
[1] Univ Lausanne, Inst Biochem, CH-1066 Epalinges, Switzerland
[2] Glaxo Wellcome Res & Dev Ltd, Med Res Ctr, Dept Cell Biol, Stevenage SG1 2NY, Herts, England
[3] Imperial Canc Res Fund, London WC2A 3PX, England
来源：
FEBS LETTERS | 2000年 / 485卷 / 2-3期
关键词：
TWEAK; WSL-1; TRAMP; death receptor; apoptosis;
D O I：
10.1016/S0014-5793(00)02219-5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
WSL-1/TRAMP (DR3) is a member of the tumour necrosis factor (TNF) receptor superfamily which exhibits effects on NF-kappaB activation and apoptosis, TWEAK, a novel TNF-related molecule, has been proposed as the ligand for this receptor. Utilising both human and murine TWEAK ligand, it is shown that TWEAK and WSL-1/TRAMP do not interact in an in vitro binding assay and that TWEAK binds strongly to cells that do not express WSL-1/TRAMP on the cell surface. Biological activity of TWEAK is also observed in these cells. Finally, cells isolated from WSL-1/TRAMP knockout mice are shown to retain their ability to interact with TWEAK. These results suggest that WSL-1/TRAMP is not the major receptor for TWEAK (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码：135 / 141
页数：7
相关论文
共 18 条
  • [1] Apoptosis control by death and decoy receptors
    Ashkenazi, A
    Dixit, VM
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (02) : 255 - 260
  • [2] Death receptors: Signaling and modulation
    Ashkenazi, A
    Dixit, VM
    [J]. SCIENCE, 1998, 281 (5381) : 1305 - 1308
  • [3] TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95)
    Bodmer, JL
    Burns, K
    Schneider, P
    Hofmann, K
    Steiner, V
    Thome, M
    Bornand, T
    Hahne, M
    Schroter, M
    Becker, K
    Wilson, A
    French, LE
    Browning, JL
    MacDonald, HR
    Tschopp, J
    [J]. IMMUNITY, 1997, 6 (01) : 79 - 88
  • [4] TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis
    Chicheportiche, Y
    Bourdon, PR
    Xu, HD
    Hsu, YM
    Scott, H
    Hession, C
    Garcia, I
    Browning, JL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (51) : 32401 - 32410
  • [5] Signal transduction by DR3, a death domain-containing receptor related to TNFR-1 and CD95
    Chinnaiyan, AM
    ORourke, K
    Yu, GL
    Lyons, RH
    Garg, M
    Duan, DR
    Xing, L
    Gentz, R
    Ni, J
    Dixit, VM
    [J]. SCIENCE, 1996, 274 (5289) : 990 - 992
  • [6] Caspases: the executioners of apoptosis
    Cohen, GM
    [J]. BIOCHEMICAL JOURNAL, 1997, 326 : 1 - 16
  • [7] Tumor necrosis factor receptor family members in the immune system
    Gravestein, LA
    Borst, J
    [J]. SEMINARS IN IMMUNOLOGY, 1998, 10 (06) : 423 - 434
  • [8] Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma
    Grenet, J
    Valentine, V
    Kitson, J
    Li, HM
    Farrow, SN
    Kidd, VJ
    [J]. GENOMICS, 1998, 49 (03) : 385 - 393
  • [9] A death-domain-containing receptor that mediates apoptosis
    Kitson, J
    Raven, T
    Jiang, YP
    Goeddel, DV
    Giles, KM
    Pun, KT
    Grinham, CJ
    Brown, R
    Farrow, SN
    [J]. NATURE, 1996, 384 (6607) : 372 - 375
  • [10] TWEAK induces angiogenesis and proliferation of endothelial cells
    Lynch, CN
    Wang, YC
    Lund, JK
    Chen, YW
    Leal, JA
    Wiley, SR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) : 8455 - 8459
12